期刊文献+

抗重组人组织因子途径抑制物1单抗抑制rhTFPI-1的抗凝作用 被引量:1

Anticoagulation inhibition effects of the monoclonal antibody aginst the recombinant human tissue factor pathway inhibitor 1 on rhTFPI
下载PDF
导出
摘要 目的研制抗重组人组织因子途径抑制物1单克隆抗体(rhTFPI-1 M cAb),了解其对rhTFPI-1抗凝活性的抑制作用。方法将分泌rhTFPI-1 M cAb的杂交瘤细胞注入经降植烷预处理的Balb/C小鼠腹腔中,诱生腹水。腹水先经硫酸铵沉淀处理,再用rprote in A亲和层析柱进一步纯化。对纯化后的单克隆抗体进行SDS-PAGE检测和W estern b lot分析。并用发色底物法测定rhTFPI-1 M cAb对rhTFPI-1的活性抑制。结果纯化后的抗rhTFPI-1 M cAb经SDS-PAGE检测,其纯度为98%;W estern b lot分析显示其能特异识别rhTFPI-1抗原。发色底物法检测结果表明,其能有效阻断rhTFPI-1的抗FVIIa/TF活性,M cAb浓度为8 mg/L时FVIIa/TF剩余活性达到86%;但对rhTFPI-1的抗FXa活性作用不明显,M cAb浓度为80 mg/L时FXa的剩余活性为48.4%。结论rhTFPI-1 M cAb可明显抑制rhT-FPI-1活性,阻碍rhTFPI-1对TF/FVIIa的抑制活性。纯化后的rhTFPI-1 M cAb的各项鉴定指标均较为理想,rprote inA亲和层析柱纯化方法简便易行值得推广。 Objective To develop the monoclonal antibody for the anti-recombinant human tissue factor pathway inhibitor 1 ( rhTFPI-1 ) and to investigate its anticoagulation inhibition effects on rhTFPI. Methods We injected the hybridoma cells that secrete anti-rhTFPI-1 McAb to the Balb/C mouse pretreated with pristane to induce aseites. The ascites were purified with rprotein A affinity chromatograghy. The purified anti-rhTFPI-1 McAb was analyzed by SDS-PAGE and Western blot. The inhibition effects of anti-rhTFPI-1 McAb on rhTFPI-1 were measured by chromophoric substrate assay. Results The purity of the anti-rhTFPI-1 McAb was 98% by SDS-PAGE analysis. Westem blot demonstrated that the anti-rhTFPI-1 McAb specifically reacted with rhTFPI-1. The chromophoric substrate assay showed that the anti-rhTFPI-1 McAb could effectively block the anti-TF/FVⅡa activity, but not the anti-FXa activity, of rhTFPI-1. The residual TF/FVⅡa activity was up to 86% at 8 mg/L anti-rhTFPI-1 McAb, but the residual FXa activity was 48.4% at 80 mg/L anti-rhTFPI-1 McAb. Conclusion The anti-rhTFPI-1 McAb effectively inhibits the activities of rhTFPI-1.
出处 《基础医学与临床》 CSCD 北大核心 2006年第11期1186-1190,共5页 Basic and Clinical Medicine
基金 国家十五科技攻关项目(2004BA720A06-02) 上海市重大科技攻关项目(04DZ19104) 上海市曙光计划基金(02SG05)
关键词 单克隆抗体 组织因子途径抑制物 rprotein A亲和层析法 monoclonal antibody tissue factor pathway inhibitor rprotein A affinity chromatography
  • 相关文献

参考文献14

  • 1Girard TJ,Warren LA,Novotny WF,et al.Brown SG,Miletich JP.Functional significance of the Kunitz-type inhibitory domains of lipoprotein associated coagulation inhibitor[J].Nature,1989,338 (6215):518-520. 被引量:1
  • 2Bajaj Ms,Birktoft JJ,Steer SA,et al.Structure and biology of tissue factor pathway inhibitor[J].Thromb Haemost,2001,86(4):959 -972. 被引量:1
  • 3Hao Bai,Duan Ma,Yu-Gao Zhang,et al.Molecular design and characterization of recombinant long half-life mutants of human tissue factor pathway inhibitor[J].Thromb Haemost,2005,93:1055-1060. 被引量:1
  • 4白浩,马端,宋后燕,莫炜,顾银良,孔德升,郭泓珅.重组TFPI缺失突变体TFPI_(1-161)在毕赤酵母中的高效表达及功能鉴定[J].生物工程学报,2004,20(6):937-942. 被引量:1
  • 5于敏,王羽雄,顾银良,宋后燕.可溶性组织因子的基因克隆、表达与性质研究[J].药物生物技术,2002,9(3):128-132. 被引量:5
  • 6任军,黄阳滨,汤其群,吴晓俐,涂宣林,顾银良,朱运松,宋后燕.基因工程链激酶的中试研究[J].药物生物技术,1996,3(2):65-68. 被引量:3
  • 7Nakamura Y,Nakamura K,Ohta K,et al.anti-inflammtory effects of long-lasting locally-delivered human recombinant tissue factor pathway inhibitor after balloon angioplasty[J].Basic Res Cardiol,2002,97(3):198 -205. 被引量:1
  • 8Hembrough TA,Swartz Gm,Papath anassiu A,et al.Tissue factor/factor VⅦa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism[J].Cancer Res,2003,63 (11):2997-3000. 被引量:1
  • 9Hembrough TA,Ruiz JF,Swerdlow BM,et al.Identification and characterization of a very low density lipoprotein receptor binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity[J].Blood,2004,103 (9):3374-3380. 被引量:1
  • 10Hembrough TA,Ruiz JF,Papathanassia AE,et al.Tissue factor pathy inhibitor inhibits endothelial cell proliferation via association wth the very low density lipoprotein receptor[J].J Biol Chem,2001,276 (15):12241-12248. 被引量:1

二级参考文献19

  • 1Wesselschmidt R, Likert K, Girard T et al. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa. Blood, 1992, 79(8): 2004 - 2010 被引量:1
  • 2Nordfang O, Bjorn SE, Valentin S et al. The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity.Biochemistry, 1991, 30(43): 10371 - 10376 被引量:1
  • 3Mine S, Yamazaki T, Miyata T et al. Structural mechanism for heparin-binding of the third Kunitz domain of human tissue factor pathway inhibitor. Biochemistry, 2002, 41( 1): 78- 85 被引量:1
  • 4Neels JG, van Den Berg BM, Lookene A et al. The second and fourth cluster of class A cysteine-rich repeats of the low density lipoprotein receptor-related protein share ligand-binding properties.J Biol Chem, 1999, 274(44): 31305 - 31311 被引量:1
  • 5Park CT, Creasey AA, Wright SD. Tissue factor pathway inhibitor blocks cellular effects of endotoxin by binding to endotoxin and interfering with transfer to CD14. Blood, 1997, 89(12): 4268-4274 被引量:1
  • 6Horie S, Hiraishi S, Hamuro T et al. Oxidized low-density lipoprotein associates strongly with carboxy-terminal domain of tissue factor pathway inhibitor and reduces the catalytic activity of the protein. Thromb Haemost, 2002, 87(1): 80 - 85 被引量:1
  • 7Johnson K, Zaror I, Bauer D et al. Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor. Thromb Haemost, 1998, 80(4): 585 - 587 被引量:1
  • 8Yang Yinke, He Xiaofan, Li Juncheng et al. Preparation and characterization of monoclonal antibody against recombinant human tissue factor pathway inhibitor. Chin Med J ( Engl ), 1998, 111(8): 718- 721 被引量:1
  • 9Holst J, Lindblad B, Westerlund G et al. Pharmacokinetics and delayed experimental anti-thrombotic effect of two domain nonglycosylated tissue factor pathway inhibitor. Thromb Res, 1996, 81(4) : 461 - 470 被引量:1
  • 10Rao LV, Nordfang O, Hoang AD et al. Mechanism of antithrombinⅢ inhibition of factor Ⅶa/tissue factor activity on cell surfaces.Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor Ⅶa/tissue factor activity. Blood, 1995, 85(1): 121- 129 被引量:1

共引文献6

同被引文献16

  • 1FloegeJ, Burns MW, Alpers CE, et al. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kideny Int, 1992, 41(2) : 297-309. 被引量:1
  • 2Plank C, Hartner A, Klanke B, et al. Adrenomedullin reduces mesangial cell number and glomerular inflammation in experimental mesangioproliferative glomerulonephritis. Kidney Int, 2005, 68 (3) : 1086-1095. 被引量:1
  • 3Kamikubo Y, Nakahara Y, Takemoto S, et al. Human recombinant tissue-factor pathway inhibitor prevents the proliferation of cultured human neonatal aortic smooth muscle cells. FEBS Len, 1997, 407(1) :116-120. 被引量:1
  • 4Hamuro T, Kamikubo Y, Nakahara Y, et al. Human recombinant tissue factor pathway inhibitor induces apoptosis in cultured human endothelial cells. FEBS Lett, 1998, 421 (3) : 197-202. 被引量:1
  • 5Yamabe H, Osawa H, Inuma H, et al. Tissue factor pathway inhibitor production by human mesanglal cells in culture. Thromb Haemost, 1996, 76(2) :215-219. 被引量:1
  • 6Cunningham MA, Ono T, Hewitson TD, et al. Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis. Kidney Int, 1999, 55 (4) : 1311-1318. 被引量:1
  • 7Wang X. The expanding role of mitochondria in apoptosis. Genes Dev, 2001, 15(22): 2922-2933. 被引量:1
  • 8Baker AJ, Mooney A, Hughes J, et al. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest, 1994, 94(5) : 2105-2116. 被引量:1
  • 9Shimizu A, Kitamura H, Masuda Y, et al. Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int, 1995, 47(1) : 114-121. 被引量:1
  • 10Hembrough TA, Ruiz JF, Papathanassiu AE, et al. Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor. J Biol Chem, 2001,276(15) : 12241-12248. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部